Bladder Small Cell Neuroendocrine Carcinoma
Also known as: Small Cell Neuroendocrine Carcinoma of Bladder / Small cell neuroendocrine carcinoma of bladder (disorder)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB02379 | Beta-D-Glucose | 1 | Completed | 1 |
DB08875 | Cabozantinib | 1 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 1 | Completed | 1 |
DB14547 | Chloride ion | 1 | Completed | 1 |
DB00515 | Cisplatin | 1 | Completed | 1 |
DB01248 | Docetaxel | 1 | Completed | 1 |
DB00773 | Etoposide | 1 | Completed | 1 |
DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Completed | 1 |
DB12257 | Platinum | 1 | Completed | 1 |
DB11595 | Atezolizumab | 2 | Recruiting | 1 |
DB11794 | Berzosertib | 2 | Active Not Recruiting | 1 |
DB08875 | Cabozantinib | 2 | Recruiting | 1 |
DB00958 | Carboplatin | 2 | Recruiting | 1 |
DB00515 | Cisplatin | 2 | Recruiting | 1 |
DB00773 | Etoposide | 2 | Recruiting | 1 |
DB06186 | Ipilimumab | 2 | Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |
DB01030 | Topotecan | 2 | Active Not Recruiting | 1 |